HEADER TRANSCRIPTION 07-DEC-16 5U5S TITLE SOLUTION STRUCTURES OF BRD2 SECOND BROMODOMAIN IN COMPLEX WITH STAT3 TITLE 2 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 344-455; COMPND 5 SYNONYM: O27.1.1,REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: STAT3 PEPTIDE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2, KIAA9001, RING3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS BRD2, BRD4, BROMODOMAIN, STAT3, TH17, P300, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.ZENG,M.-M.ZHOU REVDAT 5 15-NOV-23 5U5S 1 ATOM REVDAT 4 14-JUN-23 5U5S 1 REMARK REVDAT 3 04-DEC-19 5U5S 1 REMARK REVDAT 2 29-MAR-17 5U5S 1 JRNL REVDAT 1 22-MAR-17 5U5S 0 JRNL AUTH K.L.CHEUNG,F.ZHANG,A.JAGANATHAN,R.SHARMA,Q.ZHANG,T.KONUMA, JRNL AUTH 2 T.SHEN,J.Y.LEE,C.REN,C.H.CHEN,G.LU,M.R.OLSON,W.ZHANG, JRNL AUTH 3 M.H.KAPLAN,D.R.LITTMAN,M.J.WALSH,H.XIONG,L.ZENG,M.M.ZHOU JRNL TITL DISTINCT ROLES OF BRD2 AND BRD4 IN POTENTIATING THE JRNL TITL 2 TRANSCRIPTIONAL PROGRAM FOR TH17 CELL DIFFERENTIATION. JRNL REF MOL. CELL V. 65 1068 2017 JRNL REFN ISSN 1097-4164 JRNL PMID 28262505 JRNL DOI 10.1016/J.MOLCEL.2016.12.022 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.3, CNS, TALOS REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), BRUNGER, REMARK 3 ADAMS, CLORE, GROS, NILGES AND READ (CNS), REMARK 3 CORNILESCU, DELAGLIO AND BAX (TALOS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5U5S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1000225380. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 10 MM SODIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, 2 MM EDTA, 2 MM REMARK 210 [U-2H] DTT, 100% D2O; 10 MM REMARK 210 SODIUM PHOSPHATE, 100 MM SODIUM REMARK 210 CHLORIDE, 2 MM EDTA, 2 MM [U-2H] REMARK 210 DTT, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCACB; 3D HN(COCA)CB; 3D 1H REMARK 210 -15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 3D 1H-13C FILTERED REMARK 210 NOESY ALIPHATIC; 3D 1H-13C REMARK 210 FILTERED NOESY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW 5.04, TOPSPIN, NMRPIPE, REMARK 210 PROCHECKNMR REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 3 106.73 65.76 REMARK 500 1 TYR A 25 18.01 -141.76 REMARK 500 1 ASP A 89 68.43 -101.12 REMARK 500 1 LEU B 283 -74.01 -164.96 REMARK 500 1 LEU B 284 -101.45 56.79 REMARK 500 1 GLN B 291 79.80 58.43 REMARK 500 2 LEU A 3 113.33 67.33 REMARK 500 2 PHE B 289 53.86 -98.60 REMARK 500 3 HIS A 49 68.47 -117.32 REMARK 500 3 ASP A 89 78.83 -104.89 REMARK 500 3 PHE B 289 50.37 -104.97 REMARK 500 4 LYS A 2 165.88 67.37 REMARK 500 4 ASN B 282 -79.42 66.51 REMARK 500 4 ALY B 287 132.56 73.36 REMARK 500 4 LEU B 290 81.34 65.18 REMARK 500 5 LEU A 3 110.06 66.27 REMARK 500 5 ASN B 282 -76.23 69.03 REMARK 500 5 ALY B 287 128.33 75.19 REMARK 500 6 LYS A 2 155.73 66.85 REMARK 500 6 TYR A 25 19.19 -141.48 REMARK 500 6 ASP A 89 66.72 -110.28 REMARK 500 7 LYS A 2 85.34 61.95 REMARK 500 7 LEU A 3 113.99 69.36 REMARK 500 7 PRO A 50 99.87 -68.43 REMARK 500 7 ASP A 89 76.67 -113.81 REMARK 500 7 LEU B 284 -86.97 -82.98 REMARK 500 7 ALY B 287 131.40 69.31 REMARK 500 7 PHE B 289 66.12 -109.05 REMARK 500 8 LYS A 2 67.15 62.91 REMARK 500 8 LEU A 3 117.19 73.88 REMARK 500 8 TYR A 25 20.15 -141.98 REMARK 500 8 ALY B 287 135.33 71.99 REMARK 500 9 SER A 4 -170.11 48.86 REMARK 500 9 TYR A 25 20.31 -141.67 REMARK 500 9 ASP A 89 78.96 -108.03 REMARK 500 9 ARG B 285 157.29 72.82 REMARK 500 9 ALY B 287 127.07 71.60 REMARK 500 9 PHE B 289 55.67 -93.91 REMARK 500 10 LYS A 2 166.99 66.73 REMARK 500 10 HIS A 49 70.98 -119.58 REMARK 500 10 ASP A 89 74.09 -108.57 REMARK 500 10 LEU B 284 -88.03 -155.90 REMARK 500 10 ALY B 287 151.35 72.43 REMARK 500 10 LEU B 290 -53.03 -143.14 REMARK 500 12 HIS A 90 128.78 -7.04 REMARK 500 12 ASN B 282 105.52 67.04 REMARK 500 13 LEU A 3 98.60 -69.85 REMARK 500 13 HIS A 49 69.59 -119.76 REMARK 500 13 ARG B 285 151.19 71.23 REMARK 500 13 ALY B 287 136.74 71.37 REMARK 500 REMARK 500 THIS ENTRY HAS 72 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30206 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURES OF BRD2 SECOND BROMODOMAIN IN COMPLEX WITH REMARK 900 STAT3 PEPTIDE DBREF 5U5S A 1 112 UNP P25440 BRD2_HUMAN 344 455 DBREF 5U5S B 281 292 PDB 5U5S 5U5S 281 292 SEQRES 1 A 112 GLY LYS LEU SER GLU GLN LEU LYS HIS CYS ASN GLY ILE SEQRES 2 A 112 LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 A 112 TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA LEU GLY SEQRES 4 A 112 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 A 112 LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG ASP TYR SEQRES 6 A 112 ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 A 112 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS ASP SEQRES 8 A 112 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 A 112 PHE ARG TYR ALA LYS MET PRO ASP SEQRES 1 B 12 HIS ASN LEU LEU ARG ILE ALY GLN PHE LEU GLN SER HET ALY B 287 26 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 2 ALY C8 H16 N2 O3 HELIX 1 AA1 SER A 4 SER A 19 1 16 HELIX 2 AA2 SER A 19 LYS A 31 1 13 HELIX 3 AA3 ASP A 34 GLY A 39 1 6 HELIX 4 AA4 ASP A 42 ILE A 47 1 6 HELIX 5 AA5 ASP A 52 ASN A 62 1 11 HELIX 6 AA6 ASP A 67 ASN A 86 1 20 HELIX 7 AA7 HIS A 90 MET A 110 1 21 LINK C ILE B 286 N ALY B 287 1555 1555 1.33 LINK C ALY B 287 N GLN B 288 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1